ALT FY 2024 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena

ALTAltimmune, Inc.

$353M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$20,000-95.3% YoY

Gross Profit

$20,000100.0% margin

Operating Income

-$103M-515860.0% margin

Net Income

-$95M-475295.0% margin

EPS (Diluted)

$-1.34

Cash Flow

Operating Cash Flow

-$80M

Free Cash Flow

-$80M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$139M

Total Liabilities

$16M

Stockholders' Equity

$124M

Cash & Equivalents

$37M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20,000	$426,000	-95.3%
Gross Profit	$20,000	$426,000	-95.3%
Operating Income	-$103M	-$96M	-7.6%
Net Income	-$95M	-$88M	-7.5%